Status:
COMPLETED
Drug Test Detection of Cocaine for Nasal Intubation
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Cocaine Adverse Reaction
Eligibility:
All Genders
18+ years
Brief Summary
The objective of this study is to determine whether it is possible to detect traces above national cut-offs of either cocaine's main metabolite benzoylecgonine in saliva or cocaine in blood 24 hours a...
Detailed Description
When performed by trained personnel nasotracheal intubation is a safe and effective technique for attaining a secure airway in preparation for surgery of the head and neck. Prior to nasal intubation t...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Scheduled for nasal intubation
- Proficient in spoken and written Danish
- Negative baseline cocaine saliva test
Exclusion
- Intubation to be done on awake patient
- Pregnancy
- Women of childbearing potential must produce a negative hCG urine stix to participate
- Known symptomatic coronary artery disease
- As declared by patient or noted in the patient's file
- Untreated hypertension
- As declared by patient or noted in the patient's file
- Not taking antihypertension drugs
Key Trial Info
Start Date :
March 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 27 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT05334056
Start Date
March 22 2023
End Date
May 27 2023
Last Update
June 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Copenhagen University Hospital
Copenhagen, Denmark, 2100